User profiles for Julia Rozman

Julia S. Rozman

Senior Advisory Scientist - BARDA DRIVe, ASPR, HHS
Verified email at usuhs.mil
Cited by 11522

Durability of SARS-CoV-2–specific T-cell responses at 12 months postinfection

…, RC Maves, DA Lindholm, JS Rozman… - The Journal of …, 2021 - academic.oup.com
Background Characterizing the longevity and quality of cellular immune responses to severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enhances understanding of …

[PDF][PDF] Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history

…, RE Colombo, CJ Colombo, JO Joseph, JS Rozman… - Cell host & …, 2022 - cell.com
The rapid emergence of SARS-CoV-2 variants challenges vaccination strategies. Here, we
collected 201 serum samples from persons with a single infection or multiple vaccine …

Clinician experiences with screening for social needs in primary care

…, PL Kashiri, J Pecsok, J Rozman… - The Journal of the …, 2018 - Am Board Family Med
Background: Despite clear evidence demonstrating the influence of social determinants on
health, whether and how clinicians should address these determinants remain unclear. We …

Chronic opioid prescribing in primary care: factors and perspectives

…, RT Sabo, V Jiang, T Day, JS Rozman… - The Annals of Family …, 2019 - Annals Family Med
BACKGROUND Primary care clinicians write 45% of all opioid prescriptions in the United
States, but little is known about the characteristics of patients who receive them and the …

[HTML][HTML] Understanding'hybrid immunity': comparison and predictors of humoral immune responses to SARS-CoV-2 infection and COVID-19 vaccines.

…, MS Edwards, C English, JS Rozman… - Clin. infect …, 2022 - pesquisa.bvsalud.org
BACKGROUND: Comparing humoral responses in SARS-CoV-2 vaccinees, those with
SARS-CoV-2 infection, or combinations of vaccine/infection ('hybrid immunity'), may clarify …

Persistent COVID-19 symptoms at 6 months after onset and the role of vaccination before or after SARS-CoV-2 infection

…, J Rusiecki, E Ewers, NJ Epsi, JS Rozman… - JAMA network …, 2023 - jamanetwork.com
Importance Understanding the factors associated with post-COVID conditions is important
for prevention. Objective To identify characteristics associated with persistent post–COVID-19 …

Understanding “hybrid immunity”: comparison and predictors of humoral immune responses to severe acute respiratory syndrome coronavirus 2 infection (SARS-CoV …

…, MS Edwards, C English, JS Rozman… - Clinical Infectious …, 2023 - academic.oup.com
Background Comparison of humoral responses in severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) vaccinees, those with SARS-CoV-2 infection, or combinations of …

Performance of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) instrument in patients with coronavirus disease 2019

…, C Madar, C Lanteri, JS Rozman… - Open Forum …, 2021 - academic.oup.com
Background The inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) is a patient-reported
outcome data collection instrument assessing symptoms of viral respiratory tract …

[HTML][HTML] SARS-CoV-2 infection is associated with self-reported post-acute neuropsychological symptoms within six months of follow-up

…, C English, M Sanchez Edwards, JS Rozman… - Plos one, 2024 - journals.plos.org
Background Chronic neuropsychological sequelae following SARS-CoV-2 infection, including
depression, anxiety, fatigue, and general cognitive difficulties, are a major public health …

COVID-19 patient-reported symptoms using FLU-PRO plus in a cohort study: associations with infecting genotype, vaccine history, and return to health

…, CJ Maldonado, MP Simons, JS Rozman… - Open forum …, 2022 - academic.oup.com
Background Patient-reported outcomes of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infection are an important measure of the full burden of coronavirus disease (…